Morepen Laboratories share price
You have to be logged in to add this to Watchlist.- ₹38.84(-0.03%)February 18, 2026 12:13:47 PM IST
- NSE
- BSE
- Vol : 526.43 K (NSE + BSE)Last 20 day avg : 2.32 M
Morepen Laboratories is trading -0.03% lower at Rs 38.84 as compared to its last closing price. Morepen Laboratories has been trading in the price range of 39.13 & 38.55. Morepen Laboratories has given -5.36% in this year & -2.63% in the last 5 days. Morepen Laboratories has TTM P/E ratio 22.63 as compared to the sector P/E of 24.10.The company posted a net profit of 27.51 Crores in its last quarter.Listed peers of Morepen Laboratories include Divi's Laboratories (1.18%), Torrent Pharmaceuticals (-1.07%), Sun Pharmaceutical Industries (0.71%).The Mutual Fund holding in Morepen Laboratories was at 0.05% in 30 Sep 2023. The MF holding has - from the last quarter. The FII holding in Morepen Laboratories was at 1.62% in 31 Dec 2025. The FII holding has decreased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
Updated on Feb 18, 2026, 06:43 AM UTC
- BetaLow volatility0.70Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To EquityHigher than industry0.09The debt-to-equity ratio, indicating a company's financial leverage.
- Dividend YieldLower than industry0.53Annual dividends as a percentage of the stock price.
- PEG RatioIndicates overvaluation5.14The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
- P/E-Price-to-earnings ratio based on trailing 12-month earnings
- P/B-The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
|
| ||||
|
| ||||
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|---|
| Divi's Laboratories | Neutral | 6,258.00 | 1.18 | 1,65,915.64 | 78.61 | 11.52 | 0.46 | 0.01 |
| Torrent Pharmaceuticals | Bullish | 4,212.85 | -1.07 | 1,42,450.82 | 67.32 | 17.1 | 0.83 | 17.62 |
| Sun Pharmaceutical Industries | Bullish | 1,729.65 | 0.71 | 4,14,725.56 | 36.24 | 5.77 | 0.92 | 0.50 |
| Dr Reddy's Laboratories | Bullish | 1,280.95 | -0.32 | 1,06,890.33 | 18.63 | 3.14 | 0.63 | 2.34 |
| Cipla | Neutral | 1,341.50 | -0.14 | 1,08,343.62 | 22.95 | 3.87 | 0.87 | 0.81 |
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2026-02-10 | Quarterly Results |
| 2025-11-14 | Quarterly Results |
| 2025-08-06 | Quarterly Results & Others |
| 2025-05-12 | Audited Results & Final Dividend |
| 2025-02-06 | Quarterly Results |
- IndustryBiotechnology & Drugs
- ISININE083A01026
- BSE Code500288
- NSE CodeMOREPENLAB
Morepen Laboratories is trading at 38.84 as on Wed Feb 18 2026 06:43:47. This is -0.03% lower as compared to its previous closing price of 38.85.
The market capitalization of Morepen Laboratories is 2123.33 Cr as on Wed Feb 18 2026 06:43:47.
The 52 wk high for Morepen Laboratories is 70.40 whereas the 52 wk low is 33.47
Morepen Laboratories can be analyzed on the following key metrics -
- TTM P/E: 22.63
- Sector P/E: 24.10
- Dividend Yield: 0.51%
- D/E ratio: -
Morepen Laboratories reported a net profit of 118.02 Cr in 2025.
The Mutual Fund Shareholding was 0.05% at the end of 30 Sep 2023.